We are live on
!
Find out more
Inhibikase Therapeutics
IKT
IKT
2.50
USD
-0.02
0.79%
At close
Updated
Sep 4, 4:00 PM EDT
Pre-market
After hours
2.43
-0.07
2.8%
1 day
-0.79%
5 days
3.73%
1 month
2.46%
3 months
50.6%
6 months
28.21%
Year to date
28.21%
1 year
46.2%
5 years
-82.85%
10 years
-95.79%
New
Increased
Maintained
Reduced
Closed
Mega AUM
Over $200B
Large AUM
$10B to $200B
Mid AUM
$2B to $10B
Small AUM
$250M to $2B
Micro AUM
Under $250M
Less than 10%
Less than 20%
Less than 40%
Less than 60%
Less than 80%
| # | Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|---|
| 26 |
JFG
26
Jefferies Financial Group
New York
| $48.1K | +$36.9K | +14,800 | New |
|
| 27 |
27
Stifel Financial
St. Louis,
Missouri
| $42.7K | +$32.8K | +13,129 | New |
|
| 28 |
28
Morgan Stanley
New York
| $23.7K | +$14K | +5,629 | +338% |
|
| 29 |
29
Bank of America
Charlotte,
North Carolina
| $14.7K | +$11.1K | +4,456 | +8,408% |
|
| 30 |
30
Wells Fargo
San Francisco,
California
| $543 | – | – | – |
|
| 31 |
SAM
31
Synergy Asset Management
Vancouver,
Washington
| $65 | +$125 | +50 | New |
|
| 32 |
AC
32
Armistice Capital
New York
| – | -$814K | -626,500 | Closed |
|
| 33 |
33
Renaissance Technologies
New York
| – | -$25.9K | -19,922 | Closed |
|
| 34 |
TRCT
34
Tower Research Capital (TRC)
New York
| – | -$5.27K | -4,057 | Closed |
|